|
|
Office Locations:
|
Schwarzwaldallee 215 4058
Basel,
Switzerland
| |
|
|
|
|
|
|
Energy & Clean Tech
Food & Agriculture
Life Sciences & Healthcare
Medical Device
|
|
|
|
Syngenta has 49,000 employees in over 100 countries dedicated to bringing plant potential to life. Syngenta Ventures makes equity investments in early stage technology and product companies which align with the mission of Syngenta. Specialties include: pharmaceuticals, biotechnology, agricultural biotech, biofuels, and medical devices. Syngenta Ventures invests globally in amounts ranging between $500,000 to $5,000,000. As one of the most active investors in agriculture, Syngenta has invested over US$100m since 2006.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
